Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells.

about

Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells.

Item

http://www.wikidata.org/entity/Q49479651

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Enhancement of cisplatin cytot ...... DR5 in prostate cancer cells.

@en

Enhancement of cisplatin cytot ...... DR5 in prostate cancer cells.

@nl

type

Item

label

Enhancement of cisplatin cytot ...... DR5 in prostate cancer cells.

@en

Enhancement of cisplatin cytot ...... DR5 in prostate cancer cells.

@nl

prefLabel

Enhancement of cisplatin cytot ...... DR5 in prostate cancer cells.

@en

Enhancement of cisplatin cytot ...... DR5 in prostate cancer cells.

@nl

P1476

Enhancement of cisplatin cytot ...... DR5 in prostate cancer cells.

@en

P2093

Chunwen Yue

http://www.w3.org/2001/XMLSchema#string

Denglu Zhang

http://www.w3.org/2001/XMLSchema#string

Deqing Sun

http://www.w3.org/2001/XMLSchema#string

Jing Wu

http://www.w3.org/2001/XMLSchema#string

Juan Li

http://www.w3.org/2001/XMLSchema#string

Rongmei Wang

http://www.w3.org/2001/XMLSchema#string

Shikang Wang

http://www.w3.org/2001/XMLSchema#string

Yanxia Guo

http://www.w3.org/2001/XMLSchema#string

Yongqing Liu

http://www.w3.org/2001/XMLSchema#string

Zhaomin Lin

http://www.w3.org/2001/XMLSchema#string

P2860

XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer

Nucleotide excision repair gene (ERCC1) deficiency causes G(2) arrest in hepatocytes and a reduction in liver binucleation: the role of p53 and p21

Cancer statistics, 2016

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.

Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.

Chemotherapy for advanced hormone refractory prostate cancer.

Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.

P304

2871-2880

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.7664

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29435013

http://www.w3.org/2001/XMLSchema#string

P932

5778852

http://www.w3.org/2001/XMLSchema#string